WINNIPEG, Jan. 23 /CNW/ - IMRISneuro today announced that Capital Health has purchased its advanced neurosurgical imaging system, IMRISneuro, for the Stollery Children's Hospital and University of Alberta Hospital.
The only one of its kind in the world, IMRISneuro incorporates a moveable high field MRI into the surgical suite providing timely, high resolution images to the medical team during an operation. These images provide surgeons with richer information during surgery from which they can make better decisions for their patients.
"By investing in this leading edge technology, we continue to strive to meet our goal of providing the best medical treatment and outcomes for our patients," said Deb Gordon, Vice President and Chief Operating Officer, University of Alberta Hospital, Stollery Children's Hospital and the Mazankowski Alberta Heart Institute. "We are grateful for the support of our foundations, who made this investment in patient care possible."
No other system offers the same degree of safety for both the surgical team and the patient. IMRISneuro does not require the patient to be transported for scanning, so the optimum position for neurosurgery is never compromised. Clinical workflow and surgical access to the patient is not impacted and the magnet is removed completely from the operating room when scanning is complete. With IMRISneuro, the surgical team is not required to work within a magnetic field for the entire surgery.
"We are proud to support the goals of Capital Health and to contribute to the delivery of such a high level of patient care," said David Graves, President and CEO of IMRIS. "It's also important to us that Canadians have access to what we believe is the most advanced surgical imaging system in the world."
IMRISNeuro, with its wide bore, 1.5 Tesla iMRI unit can transition into and out of the operating room on demand, providing timely surgical imaging in addition to high quality diagnostic services when the system is not required for surgeries. This patented ability also provides a high level of financial value to the hospital.
IMRIS is a global leader in surgical imaging solutions designed to improve patient outcomes and help them live longer and more enjoyable lives. IMRIS' key technology benefits of high resolution MR images, improved patient safety, enhanced surgical efficiency and increased financial viability for hospitals contribute to a breakthrough surgical imaging offering. The Company's lead product, IMRISneuro, has been validated by leading U.S. neurosurgeons and is increasingly being used by world-class neuroscience centres. IMRIS core MRI technology has multiple product applications with a second product suite, IMRIScardio, which is actively under development.
For more information, see www.imris.com
This press release may contain or refer to forward-looking information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management's reasonable assumptions, there can be no assurance that actual results will be consistent with such statements. Forward-looking statements are subject to significant risks and uncertainties, and other factors that could cause actual results to differ materially from expected results. These forward-looking statements are made as of the date hereof and we assume no responsibility to update or revise them to reflect new events or circumstances.